Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06868121 · ClinicalTrials.gov registry record · NA

AYA OMGYES Sexual Health Study

A NA study of Sexual Dysfunction, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06868121 is a NA study of Sexual Dysfunction that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 30 participants, below the 966-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06868121, a NA study of Sexual Dysfunction, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the impact of the web-based intervention OMGYES.com on sexual dysfunction in young adult (YA) female-bodied cancer survivors. This pilot trial seeks to evaluate the intervention's: * feasibility * acceptability * appropriateness. Researchers will utilize an active observation period to compare outcomes between those receiving the intervention immediately and those who haven't Participants will: * Complete online modules at home * Visit the clinic every 5 weeks for questionnaires

Conditions Studied

Interventions

  • OTHER OMGYES.com

Study Locations (1)

Illinois

  • University of Chicago Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-16
Est. Completion 2026-05-01
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT06868121

The ClinicalTrials.gov registry entry for NCT06868121 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 966-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (97% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sexual Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which OMGYES.com is the first listed.

NCT06868121 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06868121 about?

NCT06868121 is a clinical study titled "AYA OMGYES Sexual Health Study". The purpose of this study is to assess the impact of the web-based intervention OMGYES.com on sexual dysfunction in young adult (YA) female-bodied cancer survivors. This pilot trial seeks to evaluate the intervention's: * feasibility * acceptability * appropriateness. Researchers will utilize an a...

What is the current status of trial NCT06868121?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-16. Estimated completion is 2026-05-01.

What conditions does trial NCT06868121 study?

This clinical trial studies the following conditions: Sexual Dysfunction.

What interventions are being tested in trial NCT06868121?

The interventions under investigation include: OMGYES.com (OTHER).

Who is sponsoring clinical trial NCT06868121?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06868121 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexual Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.